Fertigyn HP 2000 Injection contains Human Chorionic Gonadotropin (hCG) at a strength of 2000 IU, a hormone used primarily in fertility treatments. hCG mimics the luteinizing hormone (LH) surge in the body, which triggers ovulation in women and stimulates testosterone production in men. This injection is commonly prescribed to induce ovulation in women undergoing assisted reproductive technologies such as in vitro fertilization (IVF) or intrauterine insemination (IUI). It is also used to treat certain conditions related to hypogonadism in men by promoting testosterone synthesis and supporting spermatogenesis. Fertigyn HP 2000 Injection is administered under medical supervision, typically via intramuscular or subcutaneous injection, with dosage and timing tailored to individual treatment protocols. Patients should follow their healthcare provider’s instructions carefully to optimize treatment outcomes and minimize potential side effects, which may include injection site reactions, headache, fatigue, or, rarely, ovarian hyperstimulation syndrome (OHSS) in women. This medication should not be used in cases of hormone-sensitive cancers or allergies to hCG. Proper storage and handling are essential to maintain the medication’s efficacy. Fertigyn HP 2000 Injection plays a crucial role in enhancing fertility and hormonal balance when used appropriately.